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FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTS! 
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Sixty-two adults who underwent orthotopic liver 
transplantations between February 1981 and June 
1983 were followed for a mean of 170 days after the 
operation. Twenty-six patients developed 30 episodes of 
significant fungal infection. Candida species and Toru-
lopsis glabrata were responsible for 22 episodes and 
Aspergillus species for 6. Most fungal infections oc-
curred in the first month after transplantation. In the 
first 8 wee)ts after transplantation, death occurred in 
69% (18/26) of patients with fungal infection but in only 
8% (3/36) of patients without fungal infection 
(P<0.0005). The cause of death, however, was usually 
multifactorial, and not solely due to the fungal infection. 
Fungal infections were associated with the following 
clinical factors: administration of preoperative steroids 
(P<0.05) and antibiotics (P<0.05), longer transplant 
operative time (P<0.02), longer posttransplant opera-
tive time (P<O.Ol), duration of antibiotic use after 
transplant surgery (P<O.OOl), and the number of ste-
roid boluses administered to control rejection in the first 
2 posttransplant months (P<O.Ol). Patients with pri-
mary biliary cirrhosis had fewer fungal infections than 
patients with other underlying liver diseases (P<O.05). 
A total of 41 % (9/22) of Candida infections resolved, but 
all Aspergillus infections ended in death. 
Fungal infections have been reported following abdominal 
surgery (1, 2), in hematologic and other malignancies associated 
with leukopenia, (3-5) and in other immunosuppressed individ-
uals including transplant patients (6, 7). A high rate of Candida 
and other fungal infections has been documented by Schroter 
et a1. (8) in liver transplant patients on azathioprine and 
prednisone immunosuppression. Recently, we reported that 
liver transplant patients on cyc!osporine and prednisone had a 
higher incidence of serious fungal infections than kidney, heart, 
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and heart and lung transplant patients on comparable immu-
nosupression (9, 10) 
Many authors have sought to specify factors that predispose 
to fungal infection (1, 6, 7, 11) but few have based their analyses 
on a group of patients with similar diagnoses or procedures. 
We studied fungal infections in a group of 62 adult liver 
transplant recipients treated with cyclosporine and steroids, in 
order to define factors that influenced the development of these 
infections, and to determine the morbidity and mortality as-
sociated with them. 
MATERIALS AND METHODS 
Sixty-nine adults received orthotopic liver transplants at 
Presbyterian-University Hospital between February 1981 and 
June 1983. Information regarding their course was gathered by 
review of in-patient and out-patient charts. Six patients who 
died within 24 hr of the operation and one patient whose chart 
was unavailable were excluded, leaving 62 analyzable patients. 
Follow-up ranged from 4 to 594 days (mean: 170 days), and 
survivors were followed for at least 2 month. Fifteen retrans-
plantation operations were performed, twelve during the first 
two months of follow-up. 
All patients were treated with cyc!osporine and corticoste-
riods. Prophylactic antibiotics included a cephalosporin and a 
penicillin or an aminoglycoside administered before the opera-
tion and for various periods after surgery. In addition, the 
patients received nystatin 400,000 IU orally four times a day 
beginning at transplantation and continuing at least through-
out their initial hospitalization. The technical details of the 
operation and postoperative care have been described previ-
ously (12). 
An attempt was made to include only significant fungal 
infections. These required (1) isolation or histologic evidence 
of a fungus from an ordinarily sterile site or a site not usually 
colonized by fungi, and (2) histologic evidence oftissue invasion 
and/or other clinical or laboratory evidence of significant in-
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fection such as positive cultures from multiple sites, the pres-
ence of an abscess or empyema, and clinical abnormalities such 
as fever, leukocytosis, or pyuria. Patients who satisfied only 
criterion I-such as those with colonization and trivial infec-
tions represented by isolations of fungi, usually Candida, from 
throat, skin, urine, or sputum, nasa tracheal aspirates, and 
surgical drainage tubes without associated clinical abnormali-
ties-were excluded. Dissemination was defined as the presence 
of fungal infection in two or more sites separated by anatomical 
tissue planes (e.g., thorax and abdomen, thyroid and brain). 
Candida infections included all those identified as C. albicans, 
C. tropicalis, and C. stellatoidea. Torulopsis glabrata infections 
were also included. 
An infection was defined as associated with death when it 
was a major diagnosis at autopsy-or, if no autopsy was per-
formed, when the infection was an important concern in the 
care of the patient at the time of death. An episode of infection 
was defined as a single occurrence during which the patient 
was infected with the same genus of fungus regardless of the 
number of cultures or sites from which it was isolated. Concur-
rent infections with different genera were counted as separate 
episodes. 
To identify preoperative and postoperative factors associated 
with the development of fungal infections, the group was first 
divided. into patients who developed a fungal infection after 
transplantation and those who did not. Then the frequency of 
risk and associative factors in these two groups was determined. 
Preoperative factors studied were the pathologic diagnosis of 
the patient's liver disease, the use of systemic steroids within 
three months prior to the operation and the use of systemic 
antibiotics within a two-week period before transplantation. 
Immediate pretransplantation steroids and prophylactic anti-
biotic therapy were not counted, because all patients received 
such therapy. Preoperative liver function and nutritional status 
were assessed by reviewing the patients' preoperative pro-
thrombin times, partial thromboplastin times, and serum al-
bumin levels. The duration of operative time was taken as the 
TABLE 1. Fungal infections in liver transplant recipients 
All Male Female 
patients patients patients 
Number 62 28 34 
No. with fungal infec- 26 (42%) 14 (50%) 12 (35%) 
tions (%) 
Episodes of fungal in- 30/62 (0.48) 17/28 (0.61) 13/34 (0.38) 
fection per patient 
Deaths, all causes 29/62 (47%) 17/28 (57%) 13/34 (38%) 
Deaths associated with 20/62 (32%) 10/28 (36%) 9/34 (26%) 
fungus infections 
time from first skin incision to skin closure, as· indicated on 
the anesthesia record. 
Postoperative factors studied were the total operative time' 
of all posttransplant reoperation(s)-either for correction of 
technical deficiencies and/or subsequent retransplantations 
the duration of antibiotic therapy, the number of bacterial 
infections, and the number of presumed rejection episodes. The 
duration of antibiotic therapy was defined as the number of 
days a patient received any systemic antibiotic divided by that 
patient's total days of follow-up in the first month. Courses of 
antifungal therapy were not included. The presence of bacterial 
infection was determined by positive culture from a normally 
sterile site if the isolate was clinically determined to be signifi-
cant. Two indices of rejection were used. First, the number of 
i.v. boluses of 100 mg or more of hydrocortisone (or equivalent) 
given in addition to normal maintenance steroid therapy were 
summed and divided by the total number of follow-up days in 
the first and second months. The routine bolus that patients 
received immediately postoperatively was not counted. Second, 
the number of recycles of steroids, defined as the administration 
of high doses of oral steroids with daily decrements for about 5 
days until maintenance dosages were achieved, were similarly 
summed and divided by the total follow-up days in the first two 
follow-up months. Thus numbers were obtained for each pa-
tient that represented mean bolus frequency and mean recy-
cling frequency. 
Statistical comparisons between the two groups were made 
using chi-squared analysis (to compare proportions) and the 
unpaired t test (to compare means). Differences were consid-
ered significant if the P value was less than 0.05. 
RESULTS 
The 62 patients consisted of 28 male and 34 female patients 
(Table 1). Twenty-six patients (42% of the total group) had 30 
episodes of fungal infection including four patients with two 
fungal infections. Fourteen male patients had 17 fungal infec-
tions (three with two episodes each) and 12 female patients had 
13 infections. There was no signficant difference in the propor-
tion of male or female patients developing fungal infection or 
in their mean number of infections. Twenty-nine (47%) of the 
patients died during the follow-up period, and 20 (69%) of the 
patients who died had fungal infections. 
Table 2 shows the type of fungal infections and their courses. 
Candida caused 73% and Aspergillus species 20% of all fungal 
infections. Cryptococcus and Mucor each caused one significant 
infection. Single fungal infection was associated with 18 deaths; 
one patient had two fungal infections at death (Candida and 
Mucor). All six patients with Aspergillus infection died. Candida 
infection was present at death in 13 cases. Nine episodes of 
TABLE 2. Type and course of fungal infections 
!'lo. episodes 
No. disseminated 
Episodes associated with death 
Episodes resolved 
, Percentages of all fungal ~"iIodes 
b Percentage of all Candice: infectlons. 
C Percentage of all Asper"litus episodes. 
Candida Aspergillus 
22 (73%)" 6 (20%) 
10 4 
13 (59%)' 6 (100%)' 
9 (41 %)6 0(0%)' 
Cryptococcus 
1 (3%) 
1 
0 
Mucor 
113%) 
0 
1 
0 
Total 
:30 1100%) 
16 
20 
10 
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Candida inff:('tlOll and one episode of cryptococcal infection 
resolved. 
Figure 1 shows the time of onset and type of fungal infections 
in the patients studied. Of all fungal infections, 80% (24/30) 
occurred in the first month after transplant, and 90% occurred 
in the first two months after transplant. Among the candidal 
infections 19 of 22 and among the Aspergillus infections 4 of 6 
were diagnosed in the first four weeks after transplantation. 
Only three fungal infections were seen after the first two 
months of follow-up. 
Figure 2 shows that only 3 (8 %) of 36 patients without fungal 
infection, but 18 (69%) of 26 patients with fungal infection, 
died in the first 8 weeks after transplantation (P<0.001). Only 
four patients with fungal infection survived the overall follow-
up period. Of the 36 patients without fungal infection, 3 died 
in the first 8 weeks and a total of 7 died overall. This difference 
in survival between the two groups for the total foHow-up period 
was also significant (P<0.001). 
Details of the clinical episodes of fungal infection are given 
in Tables 3, 4, and 5. Table 3 lists Candida infections that 
resolved, Table 4 Candida infections that did not resolve, and 
Table 5 other fungal infections. Some of the infections listed 
in Table 3 might be considered localized or minor. A number 
of these patients had definite tissue evidence of invasive infec-
tion, and three patients subsequently developed Aspergillus 
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FIGURE 1. Number of episodes of fungal infections in liver trans-
plant recipients by day of first isolate. 
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, FIGURE 2. Survival of liver transplant recipients with and without 
fungal infections. 
infections confirmed at autopsy. This occurred despite ampho-
tericin thewpy (patients 38, 43, and 46). 
Risk factors and associative factors. The patients' underlying 
hepatic pathologies are shown in Table 6. There were 16 female 
patients with primary biliary cirrhosis (PBC).3 Eighteen pa-
tients had chronic active hepatitis or postnecrotic cirrhosis, or 
both. Eight patients had primary carcinoma of the liver or 
cholangiocarcinoma. Six had sclerosing cholangitis. Among the 
14 "others" were 3 patients with alpha-l antitrypsin deficiency. 
Two patients each had Caroli's disease, atypical biliary cirrho-
sis, and acute hepatic failure due to toxins. One patient each 
had Budd-Chiari syndrome, multiple adenomas of the liver, 
hemachromatosis, tyrosinemia and biliary hypoplasia. Patients 
with PBC had a better overall survival than other patients 
(P<0.05) and fewer patients with PBC developed fungal infec-
tions (P<O.05). 
Preoperative synthetic liver function was compared in the 
groups of patients with or without fungal disease. There was 
no significant difference in their liver function as estimated by 
their mean preoperative prothrombin times, partial thrombo-
plastin times, or serum albumin levels (data not shown). 
Data on the use of systemic steroids three months before 
liver transplantation were available for 58 patients. Fourteen 
. patients received preoperative steroids and 9 (64%) of these 
later developed fungal infections. Only 15 (34%) of 44 who did 
not receive systemic steroids developed fungal infections. This 
difference was significant (P<0.05). 
Information on antibiotic use in the two weeks prior to liver 
transplantation was available for 59 patients, 25 of whom 
developed fungal infections. Twenty-three patients received 
antibiotics in this interval and 14 (61 %) of them later developed 
fungal disease; 11 (31%) of 36 patients not receiving preopera-
tive antibiotics developed fungal infection after transplant 
(P<O.05). 
The operative times of the patient groups were compareci 
Those who developed a fungal infection after transplantation 
had operative times ranging from 7.6 h to 18.8 h (mean = 13.1 
h). The operative times for patients who did not subsequently 
develop a fungal infection ranged from 6.8 h to 18.3 h (mean = 
11.1 h). This difference was significant (P<O.02). The total 
time of all operations in the first month after the initial liver 
transplant ranged from 0 to 15 h (mean = 4.3 h) for those who 
subsequently developed a fungal infection and from 0 to 9.1 h 
(mean = 1.4 hr) for those who did not. This difference was also 
significant (P<O.01). 
The incidence of fungal infection was not affected by the 
type of biliary drainage procedure. Most (81%) of patients had 
primary biliary anastomosis, including 20/26 (77%) of patients 
with fungal infection and 30/36 (83%) without fungal infection. 
Figure 3 presents a comparison of the proportion of patients 
who received antibiotics during four weeks after transplanta-
tion in the two groups. On the average, the group with fungal 
infections were on systemic antibiotic 78% of the time, com-
pared with 53 % for' the group without fungal infection 
(P<0.001). Thus patients who developed fungal infections had 
more sustained antibiotic therapy than the patients who did 
not develop fungal infections. 
Of the 26 patients with fungal infections, 21 (81 %) had one 
or more documented bacterial infections. Of the 36 patients 
without fungal infection, 15 (42%) had bacterial infections 
3 Abbreviation used: PBC, primary biliary cirrhosis. 
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TABLE 3. Resolved episodes of candidal infections 
Patient 
nO. 
12 
15 
28 
32 
38 
43 
44 
46 
54 
" See Table 5. 
Sites infected 
or pathology 
Blood, abdominal abscess 
Urine, sputum, liver (biopsy) 
Bile, abdominal hematoma, 
peritoneal fluid 
Urine, sputum, peritoneal fluid, 
pleural fluid 
Wound, abdominal hematoma 
Bile, peritoneal fluid, sputum, 
chest drain 
Wound abscess, sputum, drain 
Sputum, thor'acentesis 
Urinary tract 
Day of first 
culture 
posttransplant 
12 
25 
9 
11 
26 
7 
13 
9 
9 
Note 
Treated for 1 month; pa-
tient survived 
Treated for 1 month; pa- . 
tient survived 
Bile leak repaired, drained; 
patient survived 
Infiltrate and effusion, 
treated, patient died 72 
days posttransplant, no 
autopsy 
Treated for 18 days" 
Treated for 12 days" 
Treated for 8 days, patient 
survived 
Treated for 7 days" 
Treated for 1 month 
TABLE 4. Candidal infections associated with death 
Patient 
no. 
1 
2 
4 
19 
24 
31 
33 
34 
35 
45 
so 
58 
62 
• See Table 5. 
Sites infected or 
pathology 
Wound, peritoneum, lung 
chest tube, blood, urine 
Abdominal abscess, wound 
chest tube, splenic capsule 
Blood, peritoneal fluid 
Blood, peritoneum, liver, 
kidneys, heart, lungs 
Blood, peritoneum, liver, 
spleen 
Peritoneum, rectus sheath 
abscess 
Pleural fluid, peritoneal 
fluid, blood, urine, kid-
neys, wound, heart,. ab-
dominal abscesses, lung 
Urinary tract, peritoneum 
Urine, sputum, t-tube blood 
Abdominal hematoma, 
wound, urine, sputum, 
chest tube drainage, para-
centesis fluid 
Esophagus, stomach, duo-
denum, kidneys, knee, 
lymph node, blood, lung, 
spleen, heart, liver, adre-
nal, thyroid 
Sputum, wounds, urine 
Sputum, urine, wounds 
(P<O.Ol). Despite the strong statistical association between 
bacterial infect: "n and fungal infection, there was no clear 
temporal ~c;ljueflC~ between bacterial "'ld fungal infections. 
Pa'·"nts with PBC were found to have a lower risk for the 
Day of first 
culture 
posttransplant 
19 
6 
5 
87 
24 
19 
4 
6 
20 
2 
9 
2 
24 
Day of 
death 
23 
14 
17 
91 
30 
20 
50 
9 
41 
26 
9 
19 
44 
Note 
Autopsy confirmed 
No autopsy 
Autopsy confirmed" 
Autopsy confirmed 
Autopsy confirmed 
No autopsy 
Autopsy confirmed 
Limited autopsy, not 
confirmed 
Treated for 8 days till 
death, autopsy not 
confirmed 
Treated for 11 days till 
death, no autopsy 
Autopsy confirmed 
Treated for 2 days till 
death; no autopsy 
Treated for 3 days till 
death; no autopsy 
development of fungal infections, so the prevalence of the risk 
factors discovered above was evaluated in these patients. Com-
pared with transplant recipients wi Lh other liver diseases, fewer 
recipients with PBC had antibiotics before transplantation 
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TABLE 5. Other serious fungal infections 
Patient 
no. 
4 
6 
7 
Organism 
Mucor 
Cryptococcus 
Aspergillus 
Wound 
Sites infected 
or involved 
Meninges, blood 
Lung, heart, kidneys, 
Day of first 
culture 
posttransplant 
7 
175 
7 
Day of Note death 
17 Autopsy confirmed 
439 Treated, recovered 
9 Autopsy confirmed 
esophagus, diaphragm, 
brain, rectum, spleen, 
stomach, colon, thyroid, 
pleura, lymph nodes 
20 Aspergillus 
38 Aspergillus 
43 Aspergillus 
46 Aspergillus 
48 Aspe rgillus 
Lung 
Lung, heart, thyroid 
Lung 
Lung, bladder, stomach, 
thyroid, pleural fluid, 
heart 
Lung, kidneys, pleural 
fluids, brain, thyroid 
TABLE 6. Relationship of fungal infections to pretransplant liver 
pathology 
Fungal Percentage 
Diagnosis N episodes of patients Mortality 
per patient with fungal infections 
Primary biliary cir- 16 0.19 (3/16) 19% (3/16)a 19% (3/16) 
rhosis 
Chronic active hep-
atitis and/or 
18 0.56 (10/18) 50% (9/18) 56% (10/18) postnecrotic cir· 
rhosis 
Carcinoma and 
8 0.25 (2/8) 25% (2/8) 50% (4/8) hepatoma 
. Primary sclerosing 
6 0.5 (3/6) 50% (3/6) 50% (3/6) cholangitis 
Others 14 0.86 (12/14) 64% (9/14) 64% (9/14) 
Total 62 0,48 (30/62) 42% (26/62) 47% (29/62) 
• Primary biliary cirrhosis patients compared with all other patients 
(]KO.05). 
. (P<0.02). Also, their transplant operations were of shorter 
duration (P<0.02), their total operative time during the first 
month after transplantation was shorter (P<O.OOl), and they 
were on antibiotics for fewer days after transplantation 
(P<O.05). These patients had less-complex operations, fewer 
postoperative complications, less use of antibiotics before and 
after transplantation, and fewer bacterial infections. No differ-
:nce Was found between patients with PBC and other patients 
In preoperative steroid usage or synthetic liver function. 
Fungal infections and rejection .. Rejection of the liver was 
,:ually determined clinically (rather than histologically), so we 
lDfsess~d the impact of rejection on fungal infections· in terms 
. ·anhre· t' D~e '. Jec lOn treatment-namely, the number of steroid bol-
Sand number of recycles of steroid therapy in the first and 
the m!0sttransplant months. The mean number of boluses in 
month was 0.21 per day for patients with fungal 
and 0.15 per day for those without fungal infection. 
a follow_up period of two months, the means were 0.20 
and 0.13 per day. The difference was not significant for 
month of follow-up (0.05 <P<O.l) but was at two 
fiv:f follow-up (P<O.Ol). A recycling of steroids usually 
days. Over the total 2 months of folloWllp the patients 
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FIGURE 3. Antibiotic use in patients with fungal infections ex· 
pressed as the percentage of surviving patients who were on antibac-
terial antibiotics. 
with fungal infections received a mean of 0.96 recycles per 
patient and those without fungal infections received a mean of 
0.89 recycles per patient. This difference was not significant. 
Thus i.v. steroid boluses may have been related to the devel-
opment of fungal infections, but the relation of recycles of 
steroids to the development of fungal infections was less clear 
because almost all patients received recycling therapy. 
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A final measure suggests a relationship between fungus in-
fection and rejection. During the first month after transplan-
tation, 7 of 26 patients with fungal infection were retrans-
planted, while only 2 of 36 without such infections were retrans-
planted.. This difference is significant (P < 0.05), and it may 
also be related to the difference in the total operative time after 
transplantation between the two patient groups. The number 
of retransplantations in the infected and uninfected groups for 
the total follow-up period (9 and 6, respectively) was not 
significantly different. 
In summary, various measures of rejection suggest a relation-
ship between fungus infection and rejection. Whether the de-
velopment of fungal infection was associated with the immu-
nological process of rejection or its treatment (steroids and 
retransplantation) could not be determined by our analysis. 
DISCUSSION 
The clinical significance of fungal infections may be difficult 
to determine (5). Schroter et al. (8) noted 29 (33%) invasive 
fungal infections in 87 liver transplant recipients treated with 
azathioprine, steroids and antilymphocyte globulin. This is not 
different from our findings (26/62 or 42%). Even so, these 
authors employed a definition of fungal infection somewhat 
different from ours. They noted 31 instances of "infestation" 
that included the isolation of Candida from urine, blood, and 
other normally sterile sites, and 26 more cases of colonization. 
Neither infestations nor colonizations were included in their 
list of "infections," even though some of these cases were 
treated with amphotericin. Our definition of infection would 
include some "infestations" by their definition. To help the 
reader interpret our categories, details of the candidal infections 
included here are given in Tables 3 and 4. 
Twenty-nine of the 62 patients in this series died during the 
follow-up period. This is an improvement in survival over that 
seen in the past in patients treated with azathioprine (13, 14). 
Fungal infections were present at death in 19 of these 29 
patients. 
Most patients who died with fungal infections also had other 
conditions that contributed to their demise, such as graft rejec-
tion or necrosis, bacterial or viral infections, or hemorrhage. 
Of 19 autopsies performed, fungal infection was listed as a 
cause of death in ten. A high mortality has also been noted in 
other series of immunosuppressed patients with serious fungal 
infections (3, 6). All patients with Aspergillus infections died, 
but 41 % (9 of 24) of candida infections resolved. Eight of these 
nine patients received amphotericin therapy, and one under-
went surgical drainage of an infected abdominal hematoma. A 
patient with cryptococcal septicemia and mengingitis was 
cured, and the patient with Mucor wound infection died, but 
that infection was not a direct cause of death. It is clear from 
Figure 2 that fungal infections in liver transplant patients are 
associated with a very poor prognosis. 
One cryptococcal infection, ten Candida and four Aspergillus 
infections fulfilled our definition of dissemination. All of these 
except the cryptococcal infection were associated with death. 
Whether early treatment of these infections would have pre-
vented dissemination is unknown; It should be noted that three 
patients were treated with amphotericin and recovered from 
Candida infections. but later developed aspergillosis. In these 
patients, at least, amphotericin did not prevent a subsequent 
rat;· i\, .. :J illi"ection. This may l)p germane to studies of 
pnpilyianic amphotericin in these compromised hosts. 
Most fungal infections occurred within one month of liver 
transplant surgery (Fig. 1). This is somewhat earlier than the' 
fungal infections described in renal transplants (7) and general 
surgical patients (3). The difference may be due to the often 
poor preoperative condition of the liver transplant patients Or 
related to one or more of the risk factors discussed below. It 
shows that careful vigilance with regard to fungal infection 
must be maintained in the early post-operative period. 
The gastrointestinal tract is an important source of Candida 
which colonizes 30 to 60% of normal subjects (15). Live; 
transplantation disrupts the biliary tract and bowel, so Candida 
may be released during the operative procedure. Other Candida 
infections may be related to catheters and instrumentation. We 
did not specifically count the number of catheters in each 
patient, but all patients had i.v. and intraarterial catheters at 
some time in their course. In contrast to Candida. Aspergillus, 
Cryptococcus, and Mucor are not endogenous organisms and 
are probably acquired from the physical environment. 
The factors we found to be associated with fungal infections 
are as follows: 
A. Factor associated with decreased risk of infection: primary 
biliary cirrhosis 
B. Factors associated with increased risk of infection: 
1. Preoperative steroids 
2. Preoperative antibiotics 
3. Duration of transplant operation 
4. Duration of posttransplant operations 
5. Duration of posttransplant antibiotics 
6. Bacterial infections 
7. Treatments for rejection 
Certain factors have been previously reported to promote fungal 
infection. These are debility, malnutrition, hyperalimentation, 
antibiotics, steroids, indwelling catheters, diabetes mellitus, 
and surgical procedures-especially those involving the gas-
trointestinal tract (3, 6,7,11,16). Most studies of these factors 
have been in patient groups with mixed diagnoses or in patients 
who had undergone a variety of surgical procedures. Some are 
deductions from case reports (16) or animal studies (17). Leu-
kopenia is one important risk factor for disseminated candidi, 
asis that is seen primarily in patients with acute hematologic 
malignancies (4). It was not found in our patients. 
Preoperative prothrombin times, partial thromboplastin 
times, and serum albumin levels were analyzed as an indicator 
of the patients' nutritional status and liver function. We found 
no difference in these parameters between those who did and 
did not develop a fungal infection. 
The use of antibacterial agents has been hypothesized to 
allow over-growth of endogenous fungi and thus predispose to 
serious fungal infection (16). The patients who developed fun-
gal infection were more likely to have received antibiotics in 
the 2 weeks before transplantation. We conclude that preop-
erative antibiotic therapy does predispose to subsequent fungal 
infection. Whether this is due to increased colonization or some 
other factor is not clear ! 16). 
In experimental models, steriods have increased the severity 
of fungal infection (17). We found that steroid treatment in a 
3-month period prior to transplantation was associated with 
the subsequent development of fungal infections. 
Longer operative times were also a risk factor. It is not 
,;vssible to segregate the precis('n:dsolls for this finding. Longer 
operative times may be associat6d with a patient'b metabolic 
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or hemostatic problems or reflect technical problems a l ';llr;;ery. 
Clearly, longer operative times also result in longer exposure of 
the operative field to the environment. 
The intensity of antibiotic use after the operation was also 
associated with the occurrence of fungal infection. As would be 
expected from this finding, patients with fungal infections were 
more likely to have bacterial infections. In our patients we 
found no clear temporal sequence to suggest a cause-effect 
relationship. Interestingly, some authors have found a correla-
tion between fungal infection and concurrent bacterial infec-
tion, but no correlation with use of antibiotics (6, 7). 
An important concern is whether infections are associated 
with rejection of the liver transplant. The precise diagnosis of 
rejection in liver transplant recipients is often difficult, and 
tissue evidence is not always available. For this reason we used 
the institution of treatment regimens as our measure of rejec-
tion. Of three treatment regimens studied, the number of bol-
uses of steroids and the frequency of retransplantation in the 
first month were significantly associated with fungal infections. 
We have also investigated the association of bacterial and viral 
infections with rejection using these treatment criteria. Bacte-
rial infections, but not cytomegalovirus infections, were asso-
ciated with rejection as measured by steroid boluses (Ho M, 
unpublished data). In this analysis it is not possible to conclude 
whether fungal and bacterial infections are a result or a cause 
of rejection, or whether they are related to antirejection treat-
ments. 
Fungal infections have been noted to occur more frequently 
in male patients (6, 7). In our study comparison of the number 
of male and female patients with fungal infections showed no 
differences. An important finding was that there were fewer 
fungal infections and fewer deaths in patients with a preoper-
ative diagnosis of primary biliary cirrhosis (P < 0.05), all of 
whom were female. Recipients with this diagnosis were less 
likely to have received antibiotics preoperatively, their trans-
plant operations were of shorter duration, their total operative 
time in the one month posttransplant was shorter, and they 
had fewer mean days of antibiotic therapy (P < 0.05). Hence, 
we found no clear influence of sex on fungal disease despite the 
female preponderance in primary biliary cirrhosis. 
In summary, we find fungal infection to be a common, and 
at times devastating, disease in the liver transplant population. 
Our findings lend support to those who think that antibiotics, 
steroids, and surgical trauma increase the risk of fungal infec-
tions. Patients with fungal infection did receive more i.v. ste-
roids for rejection, and were more likely to undergo retrans-
plantation for graft loss. Patients with primary biliary cirrhosis 
did have a low incidence of fungal infection and a better chance 
of survival. The rate of fungal infection in our series was not 
different from that reported for liver transplant patients treated 
with azathioprine, prednisone, and antithymocyte globulin, 
despite the overall improvement in survival of liver transplant 
patients with cyclosporine therapy. There may be unique fac· 
tors in liver transp13ntation that will make the eradication of 
fungal infec; ;'.)n Gllflcult, but attention to the risk factors 
mentioned here, especially the judicious use of antibiotics and 
steroids, may help to decrease the number of fungal infections 
seen in these patients. The possible importance of monitoring 
immunosuppression must be evaluated in a separate context. 
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